Dr. Alguire studies how to enhance the training of military nurses and the effectiveness of cancer treatments. She is particularly interested in how military healthcare needs are evolving due to modern warfare and how nurses can be better prepared for these changes. Additionally, she investigates treatment options for advanced neuroendocrine cancers, examining how combinations of specific drugs can improve patient outcomes. Her work aims to create tailored solutions that enhance care delivery and patient response in both military and oncology settings.
Key findings
In her study on military nursing, she created a curriculum that equips Advanced Practice Registered Nurses (APRNs) with skills tailored to real battlefield challenges.
In a clinical trial of a drug combination for advanced neuroendocrine cancers, 7 out of 43 patients had positive responses, with an average survival time of 26.4 months.
Patients treated with the drug combination experienced about 6.5 months without disease progression, indicating potential effectiveness.
Frequently asked questions
Does Dr. Alguire study military nursing?
Yes, she focuses on redesigning training and curricula for Advanced Practice Registered Nurses in military settings.
What treatments has Dr. Alguire researched?
She has researched a combination therapy of bevacizumab, pertuzumab, and octreotide for patients with advanced neuroendocrine cancers.
Is Dr. Alguire's work relevant to cancer patients?
Yes, her research is directly relevant to patients with advanced neuroendocrine tumors, exploring new treatment options that may improve their survival and quality of life.
How can Dr. Alguire's research help military nurses?
Her work provides military nurses with specialized training that prepares them for the unique challenges of healthcare in battlefield situations.
What impact does Dr. Alguire's research have on learning motor skills?
She has studied how making mistakes can actually aid the learning process, which could help improve teaching methods for motor skill training.
Publications in plain English
The transformation of Cure4Kids: Expanding knowledge transfer capacity.
2024
Pediatric blood & cancer
Berg F, Conger K, Avula M, Hansen C, Chatman G +6 more
Plain English The study focused on how Cure4Kids, an online resource for pediatric cancer education, was redesigned to better support healthcare professionals working with children facing cancer and other serious illnesses. The updated platform provides free online learning opportunities to meet the needs of these professionals. This transformation is important because it aims to reduce the global differences in survival rates for children with cancer.
Who this helps: Healthcare professionals and, ultimately, children with cancer everywhere.
Operational Readiness: Redesigning Advanced Practice Registered Nurse (APRN) Curriculum for an Evolving Battlefield.
2019
Military medicine
D'Angelo MR, Seibert D, Wanzer L, Johnson H, Alguire K +3 more
Plain English This study looks at how military nursing roles are changing because of new types of warfare and healthcare needs on the battlefield. Researchers found that Advanced Practice Registered Nurses (APRNs) require different skills and knowledge than what they learn in regular healthcare settings. They created a new training curriculum that focuses on real military situations to ensure that APRNs can handle the unique challenges they will face, helping them provide better care in difficult environments.
Who this helps: This benefits military nurses and ultimately improves care for soldiers in the field.
Lee TD, Eliasz KL, Gonzalez D, Alguire K, Ding K +1 more
Plain English The researchers conducted five experiments to understand how mistakes affect learning new motor skills, specifically keypress sequences. They found that when participants had more information about which key to press next, they made fewer errors, but these errors were important for better long-term learning of the sequences. This shows that while some mistakes are helpful for improving skills, not all errors contribute positively to the learning process.
Who this helps: This research helps motor skill learners and trainers develop better teaching methods.
A Phase II Study of the Combination of Bevacizumab, Pertuzumab, and Octreotide LAR for Patients with Advanced Neuroendocrine Cancers.
2016
Cancer investigation
Bendell JC, Zakari A, Lang E, Waterhouse D, Flora D +7 more
Plain English This study looked at a combination treatment of three drugs—bevacizumab, pertuzumab, and octreotide depot—for patients with advanced neuroendocrine cancers. Out of 43 patients, 7 showed positive responses to the treatment, and the average survival time was 26.4 months, while patients lived without disease progression for about 6.5 months. The combination therapy was generally well tolerated, though some side effects like diarrhea and fatigue were common.
Who this helps: This helps patients with advanced neuroendocrine tumors.
Fair Berg Kristy Conger Meghana Avula Cameron Hansen Georgia Chatman John Provasnik Andrew Wellman Guillermo Chantada Carlos Rodriguez-Galindo Daniel C Moreira
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.